The role of green tea extract on the proliferation of human ovarian cancer cells (in vitro) study

International Journal of Cancer Research

Volumn 6, Issue 2, 2010, Pages 78-88

  Mahboub, Faiza A ^a   Khorshid, Faten A ^b  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Green tea extracts (GTEs); Ovarian cancer cells IC50; Polyphenol; Tissue culture

Indexed keywords

ANAZOLENE SODIUM; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CONTACT; CELL COUNT; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; OVARY CANCER;

EID: 78149430170     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2010.78.88     Document Type: Article

References (61)

1. Ahmad, N., D.K. Feyes, A.L. Nieminen, R. Agarwal and H. Mukhtar, 1997. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest inhuman carcinoma cells. J. Natl. Cancer Inst., 89: 1881-1886.
2. Ahmad, N., P. Cheng and H. Mukhtar, 2000. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun., 275: 328-334.
3. Aucamp, J., A. Gaspar, Y. Hara and Z. Apostolides, 1997. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anti cancer Res., 17: 4381-4385.
4. August, D.A., J. Landau, D. Caputo, J. Hong, M.J. Lee and C.S. Yang, 1999. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol. Biomarkers Prev., 8: 709-713.
5. Baliga, M.S., S. Meleth and S.K. Katiyar, 2005. Growth inhibitory and metastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res., 11: 1918-1927.
6. 2 production and oxidative DNA damage in HeLa cells by epigallocagallate (EGCG). Proc. Am. Assoc. Cancer Res., 32: 126-126.
7. Chan, M.M., K.J. Soprano, K. Weinstein and D. Fong, 2006. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J. Cell Physiol, 207: 389-396.
8. Chen, C, R. Yu, E.D. Owuor and A.N. Kong, 2000. Activation of-antioxidant-response element (ARE), mitogen-activated protein.kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res., 23: 605-612.
9. Chung, F.L., J. Schwartz, C.R. Herzog and Y.M. Yang, 2003. Tea and cancer prevention: Studies in animals and humans. J. Nutr., 133: 3268-3274.
10. Crespy, V. and G. Williamson, 2004. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr., 134: 3431-3440.
11. Dunfield, L.D., T.G. Shepherd and M.W. Nachtigal, 2002. Primary culture andmRNA analysis of human ovarian cells. Biol. Proced., 4: 55-61.
12. Frei, B. and J. V. Higdon, 2003. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr., 33: 3275-3284.
13. Fujiki, H. and M. Suganuma, 2002. Green tea and cancer prevention. Proc. Japan Acad. Ser. B, 78: 263-270.
14. Graham, H.N., 1992. Green tea composition and polyphenol chemistry. Prev. Med., 21: 334-350.
15. Gupta, S., K. Hastak, N. Ahmad, J.S. Lewin and H. Mukhtar, 2001. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Nat. Acad. Sci. USA., 8: 10350-10355.
16. Hakim, I.A., RB. Harris and U.M. Weisgerber, 2000. Tea intake and squamous cell carcinoma of the skin: Influence of type of tea beverages. Cancer Epidemiol. Biomarkers Prev., 9: 727-731.
17. Hanachi, P., S.H. Kua, R. Asmah, G. Motalleb and O. Fauziah, 2006. Cytotoxic effect of Berberis vulgaris fruit extract on the proliferation of human liver cancer cell line (HepG2) and its antioxidant properties. Int. J. Cancer Res., 2: 1-9.
18. Huh, S.W., S.M. Bae, Y.W. Kim, J.M. Lee and S. Eune et al., 2004. Anticancer effects of (-)-epigallocatechin-3- gallate on ovarian carcinoma cell lines. Gynecol. Oncol., 94: 760-768.
19. Inoue, M., K. Tajima, M. Mizutani, H. Iwata and T. Iwase et al., 2001. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) Japan. Cancer Lett., 167: 175-182.
20. Ioannides, C. and V. Yoxall, 2003. Antimutagenic activity of tea: Role of polyphenols. Curr. Opm. Clin. Nutr. Metab. Care., 6: 649-656.
21. Katdare, M., M.P. Osborne and N.T. Telang, 1998. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals Oncol. Rep., 5: 311-315.
22. Kennedy, D.O., M. Matsumoto, A. Kojima and I. Matsui, 1999. Cellular thiols status and cell death in the effect of green tea polyphenol Ehrich ascites tumor cells. Chemico. Biol. Interact, 122: 59-71.
23. Kennedy, D.O., S. Nishimura, T. Hasuma, Y. Yano, S. Otani and I. Matsuiyuasa, 1998. Involvement of protein tyrosine phosphrylation in the effect of green tea polyphenoles onEhrlichascietes tumor cells in vitro. Chem. Biol. Interact, 110: 159-172.
24. Khan, S.G., S.K. Katiyar, R. Agarwal and H. Mukhata, 1992. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in cancer prevention. Cancer Res., 52: 4050-4052.
25. Khorshid, F.A. and S.S. Moshref, 2006. In vitro anticancer agent, I-tissue culture study of human lung cancer cells A549 II-tissue culture study of mice leukemia cells LI 210. Int. J. Cancer Res., 2: 330-344.
26. Khorshid, F.A., S.S. Mushref and N.T. Heffny, 2005. An ideal selective anti-cancer agent in vitro I-tissue culture study of human lung cancer cells A549. J. KAU Med. Sci., 12: 3-19.
27. Lee, A.H., M.L. Fraser and C.W. Binns, 2005. Possible role for green tea in ovarian cancer prevention. Future Oncol., 1: 771-777.
28. 27 during growth arrest of human breast carcinoma cells by EGCG. J. Cell. Bio. chem., 75: 1-12.
29. Liao, J., G.Y. Yang, E.S. Park, X. Meng and K.K.L. Ho et al, 2001. Inhibition of angiogenesis and induction of cell apoptosis during lung carcinogenesis by green tea in A/J mice. Proc. Am. Assn. Cancer Res., 42: 575-575.
30. Lin, J.K., 2002. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch. Pharm. Res., 25: 561-571.
31. Lin, Y.L., C. Y. Cheng, Y.P. Lin, Y.W. Lau, I.M. Juan and J.K. Lin, 1998. Hypolipidemic effect of green tea leaves through induction of antioxidant and phase II enzymes including superoxide dismutase, catalase,and glutathione-S-transferase in rats. J. Agric. Food Chem., 46: 1893-1899.
32. Lu, Y.P., Y.R. Lou, X.H. Li, J.G. Xie, D. Brash, M.T. Huang and A.H. Conney, 2000. Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wildtype, p53, p21(WAFl/CIPl) and apoptotic sunburn cells in SKH-1 mice. Cancer Res., 60: 4785-4791.
33. Masuda, M., M. Suzui and LB. Weinstein, 2001. Effects of pigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, an chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 7: 4220-4229.
34. Masuda, M., M. Suzui, J.T. Lim and LB. Weinstein, 2003. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin. Cancer Res., 9: 3486-3491.
35. Matsumoto, H. and T. Yamana, 2000. Green tea and cancer prevention. J. Women Cancer, 2: 152-158.
36. Matsuzaki, T. and Y. Hara, 1985. Antioxidative activity of tea leaf catechins. J. Agric. Chem. Soc. Jpn, 59: 126-134.
37. McKay, D.L. and J.B. Blumberg, 2002. The role of tea in human health: An update. J. Am. Coll. Nutr., 21: 1-13.
38. Nagano, J., S. Kono, D.L. Preston and K. Mabuchi, 2001. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control, 12: 501-508.
39. Nakachi, K., K. Suemasu, K. Suga, T. Takeo, K. Imai and Y. Higashi, 1998. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res., 89: 254-261.
40. Nicolas, J.M., M.N. Clifford and C. lonnides, 1999. Consumption of tea modulates the urinary excretion of mutagens in rat treated with IQ Role of caffeine. Mut. Res., 441: 191-203.
41. Nihal, M.,N. Ahmad, H. Mukhtar and G.S. Wood, 2005. Anti-proliferative and proapoptotic seffects of (-)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma. Int. J. Cancer, 114: 513-521.
42. Parkin, D.M., 2001. Global cancer statistics in the year 2000. Lancet 2: 533-543.
43. Parkinson, A., 1996. Biotransformation of Xenobiotics. In: Casarett and Doull's Toxicology, The Basic Science of Poisons, Klaassen, CD. (Ed.). McGraw-Hill, New York, pp: 113-186.
44. Pollard, J.W. and J.M. Walker, 1989. Methods in Molecular Biology, Animal Cell Culture. Vol. 5, Humana Press, Clifton, New Jersey, pp: 2-10.
45. Sasazuki, S., M. Inoue, T. Hanaoka, S. Yamamoto, T. Sobue and S. Tsugane, 2004. Green tea consumption and subsequent risk of gastric cancer by subsite: The JPHC Study. Cancer Causes Control, 15: 483-491.
46. Setiawan, V.W., Z.F. Zhang and G.P. Yu, 2001. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer, 92: 600-604.
47. Su, L. J. and L. Arab, 2002. Tea consumption and the reduced risk of colon cancer-results from a national prospective cohort study. Public Health Nutr., 5: 419-426.
48. Suganuma, M., S. Okabe, N. Sueoka, E. Sueoka and S. Matsuyama et al., 1999. Green tea and cancer chemoprevention. Mutat. Res., 428: 339-344.
49. Sun, C.L., J.M. Yuan, M.J. Lee, C.S. Yang, Y.T. Gao, R.K. Ross and M.C. Yu, 2002. Urinary tea polyphenols in relation to gastric and oesophageal cancers: A prospective study of men in Shanghai, China. Carcinogenesis, 23: 1497-1503.
50. Thangapazham, R.L., A.K. Singh, A. Sharma, J. Warren, J.P. Gaddipati and R.K. Maheshwari, 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation on human breast cancer cells in vitro and in vivo. Cancer Lett, 245: 232-241.
51. Vogelstein, B., D. Lane and A. J. Levine, 2000. Surfing the p53 network. Nature, 408: 307-310.
52. WHO, 2004. The world health report 2004: Changing history. World Health Organization, Geneva, http://www.who.int/whr/2004/en/.
53. Watanable, J., J. Kawabata and R. Niki, 1998. Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci. Biotechnol. Biochem., 62: 532-534.
54. Wu, A.H., M.C. Yu, C.C. Tseng, J. Hankin and M.C. Pike, 2003. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer, 106: 574-579.
55. Yang, G., J. Liao, K. Kim, E. Yurkow and C. Yang, 1998. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19: 611-616.
56. Yang, G. Y., J. Liao, C. Li, J. Chung, E.J. Yurkow, C.T. Ho and C.S. Yang, 2000. Effect of black and green tea polyphenols on c-jun phosphorylation and H2 O 2 production in transformed and non- tranformed human bronchial cell lines: Possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis, 21: 2035-2039.
57. Yang, C.S., P. Maliakal and X. Meng, 2002. Inhibition of carcinogenesis by tea. Ann. Rev. Pharmacol. Toxicol., 42: 25-54.
58. Yihai, C. andC. Renhai, 1999. Can green tea minimize cancer risk?. Nature, 398: 381-382.
59. Yu, R., J.J. Jiao, J.L. Duh, K. Gudehithlu, T.H. Tan and A.N. Kong, 1997. Activation of mitogen-activated protein kinases by green tea polyphenols: Potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis, 18: 451-456.
60. Zhang, M., C.W. Binns andA.H. Lee, 2002. Tea consumption and ovarian cancer risk: A case control study in China. Cancer Epidemiol. Biomarkers Prev., 11: 713-718.
61. Zhang, M., A.H. Lee, C.W. Binns and X. Xie, 2004. Green tea consumption enhances survival of epithelial ovarian cancer. Int. J. Cancer, 112: 465-469.